B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up.
about
Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.Left atrial size is independently associated with cognitive function.NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus StudyAssociation of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.Cognitive impairment in heart failure patients.Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients.The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors.N-terminal pro-brain natriuretic peptide and abnormal brain aging: The AGES-Reykjavik StudyIschemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patientsMarkers of cardiac dysfunction in cognitive impairment and dementia.Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer diseaseClinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Phenotypic profiling of cognitive impairment risk among patients with heart failure: a literature review of the usefulness of cardiac-related variables.N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts.High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.Heart failure and cognitive function in the general population: the Hoorn Study.B-type natriuretic peptide and severity of cognitive disorder.Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial.The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population.The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age.N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk.High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk.Mini-Mental State Examination score and B-type natriuretic peptide as predictors of cardiovascular and total mortality in an elderly general population.N-Terminal pro-Brain Natriuretic Peptide and Associations With Brain Magnetic Resonance Imaging (MRI) Features in Middle Age: The CARDIA Brain MRI Study.
P2860
Q33848664-A35ECD39-DADD-49E1-8E17-91B550B51A00Q34200482-47C655F7-2B23-49E6-97CC-62C474556645Q34248217-1AE07CE4-2277-4AA1-B580-2D0138AFB3FFQ34413727-596D2084-7FE0-4723-BEA6-3B0B2CCDC32DQ34954444-891697AE-F9A9-44BD-841C-71E130780F1AQ35573378-C5C8A20A-AD14-408B-A848-C538DA60A39AQ35700320-6BFA4E9F-228E-4089-BA2A-5F9D6390625BQ36005627-256C39E8-2925-4A70-9832-EC4D9C9C3640Q36117728-D29BF5C6-9C6F-4B52-812E-9BDA9C38396BQ36152775-C1F6FE55-02A7-4FEA-BCA5-E4D70B3F4A03Q36183810-329F1683-7A39-4EF8-BFDC-F5E07F31E501Q36932748-05A7C5D6-330F-4048-963E-88A91FF297FDQ37106524-1F723BD9-3A3A-4581-B4EC-60CD32DC8F1CQ38072895-38880F8A-FAE7-4549-9D96-F4EC9FE1F0F4Q38388347-45C6D671-AF22-4603-B5E2-AB9580EC5353Q38406405-D6F7AFBB-9256-4AE1-8ACA-B89B966237BEQ40347969-B93BD5F9-D473-4A54-AEEA-FDFD7B309F07Q40401170-9A8570F6-FC54-49B0-9137-CA89F4D7BAC1Q44055922-DF52F2EB-F02C-4935-819E-A85F9ED9469AQ44120239-4D6F761D-86A8-40A0-8CA9-A30980A6D8EBQ48174837-EF3F84EB-4728-4109-9ADC-6DC7A928AB72Q48206492-BEB96B2D-05E4-42D0-AD96-A79FFE1E2A38Q48479424-E1FA3C5B-44C8-4E78-886F-7A42130A9C05Q48709088-326052AB-2611-4220-A02F-805319CE1137Q48901180-891DFDB2-029F-4315-B3EE-5F3071830893Q51832764-CC785FF5-F98E-4659-890C-3F446CECDCA4Q55040636-892905CC-D68F-4D6F-AE9B-CBEDC5E3531E
P2860
B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
B-type natriuretic peptide as ...... ation with a 5-year follow-up.
@en
B-type natriuretic peptide as ...... ation with a 5-year follow-up.
@nl
type
label
B-type natriuretic peptide as ...... ation with a 5-year follow-up.
@en
B-type natriuretic peptide as ...... ation with a 5-year follow-up.
@nl
prefLabel
B-type natriuretic peptide as ...... ation with a 5-year follow-up.
@en
B-type natriuretic peptide as ...... ation with a 5-year follow-up.
@nl
P2093
P2860
P1433
P1476
B-type natriuretic peptide as ...... ation with a 5-year follow-up.
@en
P2093
Olli Vuolteenaho
Raimo Kettunen
Raimo Sulkava
Tuomas Kerola
P2860
P304
P356
10.3109/07853891003652542
P407
P577
2010-04-01T00:00:00Z